Suppr超能文献

经阴道网状物治疗盆腔器官脱垂的疗效及患者满意度:加拿大视角

Efficacy and patient satisfaction of pelvic organ prolapse reduction using transvaginal mesh: A Canadian perspective.

作者信息

Aubé Mélanie, Guérin Marilyne, Rheaume Caroline, Tu Le Mai

机构信息

Department of Urology, Centre Hospitalier Universitaire de Sherbrooke (CHUS), Université de Sherbrooke, Sherbrooke, QC, Canada.

Department of Obstetrics and Gynecology, Centre Hospitalier de l'Université Laval (CHUL), Université Laval, Quebec City, QC, Canada.

出版信息

Can Urol Assoc J. 2018 Oct;12(10):E432-E437. doi: 10.5489/cuaj.5095. Epub 2018 May 28.

Abstract

INTRODUCTION

Due to U.S Food and Drud Administration warnings and class-action lawsuits, the use of transvaginal mesh for pelvic organ prolapse surgery is controversial. We report data from two Canadian centres, focusing on recurrence and reoperation rates, complication rates, and patient satisfaction.

METHODS

A retrospective medical chart review was performed. Patients were also invited to a long-term followup clinic for a complete questionnaire and gynecological exam. Patients unable to present to clinic for followup had the option to answer the questionnaire via telephone.

RESULTS

A total of 334 patients were operated between 2000 and 2013. Median followup was 38 months for questionnaire and 36 months for physical exam. Thirty-seven patients (11.1%) required repeat operation, including 17 for recurrent prolapse and 10 for mesh exposure; 98.8% of patients reported feeling subjectively improved by their prolapse surgery.

CONCLUSIONS

Midterm results are satisfactory and patient subjective satisfaction is high following transvaginal mesh repair of pelvic organ prolapse.

摘要

引言

由于美国食品药品监督管理局的警告和集体诉讼,经阴道网片用于盆腔器官脱垂手术存在争议。我们报告了来自加拿大两个中心的数据,重点关注复发率、再次手术率、并发症发生率以及患者满意度。

方法

进行了一项回顾性病历审查。患者还被邀请到长期随访诊所,进行完整的问卷调查和妇科检查。无法到诊所进行随访的患者可以选择通过电话回答问卷。

结果

2000年至2013年间共对334例患者进行了手术。问卷调查的中位随访时间为38个月,体格检查的中位随访时间为36个月。37例患者(11.1%)需要再次手术,其中17例因复发脱垂,10例因网片暴露;98.8%的患者报告脱垂手术后主观感觉有所改善。

结论

盆腔器官脱垂经阴道网片修复的中期结果令人满意,患者主观满意度较高。

相似文献

1
Efficacy and patient satisfaction of pelvic organ prolapse reduction using transvaginal mesh: A Canadian perspective.
Can Urol Assoc J. 2018 Oct;12(10):E432-E437. doi: 10.5489/cuaj.5095. Epub 2018 May 28.
2
Transvaginal surgery using self-cut mesh for pelvic organ prolapse: 3-year clinical outcomes.
Int J Urol. 2019 Jul;26(7):731-736. doi: 10.1111/iju.13984. Epub 2019 May 7.
3
Prolapse Recurrence after Transvaginal Mesh Removal.
J Urol. 2015 Nov;194(5):1342-7. doi: 10.1016/j.juro.2015.06.080. Epub 2015 Jun 25.
5
Long-term (8.5 years) analysis of the type and rate of reoperation after transvaginal mesh repair (Prolift) in 349 patients.
Eur J Obstet Gynecol Reprod Biol. 2019 Jan;232:33-39. doi: 10.1016/j.ejogrb.2018.10.009. Epub 2018 Oct 6.
6
One-year outcome of concurrent anterior and posterior transvaginal mesh surgery for treatment of advanced urogenital prolapse: case series.
J Minim Invasive Gynecol. 2010 Jul-Aug;17(4):473-9. doi: 10.1016/j.jmig.2010.03.003. Epub 2010 May 23.
7
Synthetic Graft Augmentation in Vaginal Prolapse Surgery: Long-Term Objective and Subjective Outcomes.
J Minim Invasive Gynecol. 2016 May-Jun;23(4):614-21. doi: 10.1016/j.jmig.2016.02.014. Epub 2016 Feb 23.
8
Long-term outcome after transvaginal mesh repair of pelvic organ prolapse.
Int Urogynecol J. 2016 Jul;27(7):1069-74. doi: 10.1007/s00192-015-2939-7. Epub 2016 Feb 2.
9
Surgical management of pelvic organ prolapse in women.
Cochrane Database Syst Rev. 2013 Apr 30(4):CD004014. doi: 10.1002/14651858.CD004014.pub5.
10
Reoperations for mesh-related complications after pelvic organ prolapse repair: 8-year experience at a tertiary referral center.
Int Urogynecol J. 2017 Aug;28(8):1139-1151. doi: 10.1007/s00192-016-3256-5. Epub 2017 Feb 1.

引用本文的文献

1
Prolapse Quality-of-life Questionnaire is a Reliable Postoperative Outcome Assessment.
Gynecol Minim Invasive Ther. 2025 Jul 19;14(3):215-222. doi: 10.4103/gmit.gmit_74_24. eCollection 2025 Jul-Sep.
4
Favorable Postoperative Outcomes After Transvaginal Mesh Surgery Using a Wide-Arm ORIHIME® Mesh.
Cureus. 2024 Feb 1;16(2):e53388. doi: 10.7759/cureus.53388. eCollection 2024 Feb.
5
Current surgical management of pelvic organ prolapse: Strategies for the improvement of surgical outcomes.
Investig Clin Urol. 2019 Nov;60(6):413-424. doi: 10.4111/icu.2019.60.6.413. Epub 2019 Oct 29.

本文引用的文献

1
Analysis of changes in sexual function in women undergoing pelvic organ prolapse repair with abdominal or vaginal approaches.
Int Urogynecol J. 2016 Dec;27(12):1919-1924. doi: 10.1007/s00192-016-3066-9. Epub 2016 Jun 24.
2
Native tissue repair or transvaginal mesh for recurrent vaginal prolapse: what are the long-term outcomes?
Int Urogynecol J. 2016 Sep;27(9):1313-20. doi: 10.1007/s00192-016-3069-6. Epub 2016 Jun 20.
3
Graft and Mesh Use in Transvaginal Prolapse Repair: A Systematic Review.
Obstet Gynecol. 2016 Jul;128(1):81-91. doi: 10.1097/AOG.0000000000001451.
4
Surgeon Experience and Complications of Transvaginal Prolapse Mesh.
Obstet Gynecol. 2016 Jul;128(1):65-72. doi: 10.1097/AOG.0000000000001450.
6
Transvaginal mesh or grafts compared with native tissue repair for vaginal prolapse.
Cochrane Database Syst Rev. 2016 Feb 9;2(2):CD012079. doi: 10.1002/14651858.CD012079.
7
Long-term outcome after transvaginal mesh repair of pelvic organ prolapse.
Int Urogynecol J. 2016 Jul;27(7):1069-74. doi: 10.1007/s00192-015-2939-7. Epub 2016 Feb 2.
8
Menopausal Symptoms and Their Management.
Endocrinol Metab Clin North Am. 2015 Sep;44(3):497-515. doi: 10.1016/j.ecl.2015.05.001.
9
Perioperative outcomes and prospective patient reported outcome measures for transvaginal mesh surgery.
Arch Gynecol Obstet. 2015 Oct;292(4):875-82. doi: 10.1007/s00404-015-3724-z. Epub 2015 Apr 24.
10
Transvaginal repair of stage III-IV cystocele using a lightweight mesh: safety and 36-month outcome.
Int Urogynecol J. 2015 Aug;26(8):1147-54. doi: 10.1007/s00192-015-2659-z. Epub 2015 Mar 3.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验